Sofinnova Investments’s Akero Therapeutics AKRO Stock Holding History

Sofinnova Investments’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-473,625	Closed	-$22.5M	–	61
2025 Q3	$22.5M	Sell	473,625 -75,163	-14%	-$3.64M	1.23%	26
2025 Q2	$29.3M	Buy	548,788 +38,768	+8%	+$1.76M	1.79%	20
2025 Q1	$20.6M	Buy	+510,020	New	+$21.6M	1.35%	27
2020 Q2	–	Sell	-148,415	Closed	-$3.15M	–	77
2020 Q1	$3.15M	Buy	+148,415	New	+$3.18M	0.29%	44

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sofinnova Investments's AKRO Position: Q4 2025 in Review

Sofinnova Investments sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 473,625 shares — an estimated $22.5M sold.

Sofinnova Investments first reported a position in AKRO in Q1 2020 and held it in 4 quarters. The position peaked at $29.3M in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Sofinnova Investments reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Sofinnova Investments sold 473,625 Akero Therapeutics shares in Q4 2025, an estimated $22.5M.
Sofinnova Investments first reported a position in Akero Therapeutics in Q1 2020 and held it in 4 quarters.
Sofinnova Investments's Akero Therapeutics position peaked at $29.3M in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Sofinnova Investments's 13F filing for Q4 2025, filed 13 Feb 2026.